List view / Grid view

Dr Eftychia Koumarianou (Head of the Pharmaco-Imaging and Molecular Radiotherapy (MRT) Department at Oncodesign Services)

 

article

Why radiopharmaceuticals are becoming central to precision oncology

Radiopharmaceuticals are emerging as a development platform rather than a…

2 February 2026 | By

Radiopharmaceuticals are emerging as a development platform rather than a single modality in oncology. This article explores what that means for cancer drug development and how integrated strategies can reduce risk and accelerate progress to the clinic.